Related donor bone marrow transplantation for chronic myelogenous leukemia

Hematology/Oncology Clinics of North America

Volumn 12, Issue 1, 1998, Pages 81-92

  Passweg, J R ^a   Rowlings, P A ^a   Horowitz, M M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HYDROXYUREA; METHOTREXATE;

BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; REVIEW; SIBLING; TISSUE TYPING; TREATMENT OUTCOME;

EID: 0031910352     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70497-4     Document Type: Article

References (71)

1. J. Aschan O. Ringdén B. Sundberg Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease Eur J Haematol 50 1993 269
2. R.C. Ash M.M. Horowitz R.P. Gale Bone marrow transplantation from related donors other than HLA-identical siblings: Effect of T-cell depletion Bone Marrow Transplant 7 1991 443
3. F.H. Bach R.J. Albertini P. Joo Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome Lancet 2 1968 1364
4. A. Bacigalupo F. Gualandi Van Lint M.T. Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: Impact of disease related variables (Sokal score) Bone Marrow Transplant 12 1993 443
5. P.G. Beatty R.A. Clift E.M. Mickelson Marrow transplantation from related donors other than HLA-identical siblings N Engl J Med 313 1985 765
6. D.W. Beelen U. Graeven A.H. Elmaagacli Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome–positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome Blood 85 1995 2981
7. W.I. Bensinger C.H. Weaver F.R. Appelbaum Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor Blood 85 1995 1655
8. W.I. Bensinger C.D. Buckner K. Shannon-Dorcy Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy Blood 88 1996 4132
9. M.M. Bortin O. Ringdén M.M. Horowitz Temporal relationships between the major complications of bone marrow transplantation for leukemia Bone Marrow Transplant 4 1989 339
10. M.M. Bortin M.M. Horowitz R.P. Gale Changing trends in bone marrow transplantation for leukemia in the 1980s JAMA 268 1992 607
11. R. Champlin Separation of graft-vs.-host disease and graft-vs.-leukemia effect against chronic myelogenous leukemia [editorial; comment] Exp Hematol 23 1995 1148
12. R. Champlin W. Ho E. Arenson Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase Blood 60 1982 1038
13. R.C. Champlin J. Jansen W. Ho Retention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia Transplant Proc 23 1991 1695
14. R.A. Clift R. Storb Marrow transplantation for CML: The Seattle experience Bone Marrow Transplant 17 1996 S1
15. R.A. Clift C.D. Buckner E.D. Thomas Treatment of chronic granulocytic leukemia in chronic phase by allogeneic marrow transplantation Lancet 2 1982 621
16. R.A. Clift C.D. Buckner F.R. Appelbaum Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens Blood 77 1991 1660
17. R.A. Clift C.D. Buckner E.D. Thomas Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide Blood 84 1994 2036
18. Collins R.H. Jr O. Shpilberg W.R. Drobyski Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [see comments] J Clin Oncol 15 1997 433
19. De Konig J. L.J. Dooren Van Bekkum D.W. Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency Lancet 1 1969 1223
20. A. Devergie D. Blaise M. Attal Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: A randomized trial of busulfan-cytoxan versus cytoxan–total body irradiation as preparative regimen: A report from the French Society of Bone Marrow Graft (SEGM) Blood 85 1995 2263
21. W.R. Drobyski C.A. Keever M.S. Roth Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose Blood 82 1993 2310
22. A. Fefer M.A. Cheever P.D. Greenberg Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins N Engl J Med 306 1982 63
23. R.P. Gale M.M. Horowitz R.C. Ash Identical-twin bone marrow transplants for leukemia Ann Intern Med 120 1994 646
24. RP Gale, R Hehlmann, MJ Zhang, et al. Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. Blood, in press
25. R.A. Gatti H.J. Meuwissen H.D. Allen Immunological reconstitution of sex-linked immunological deficiency Lancet 2 1968 1366
26. S.A. Giralt H.M. Kantarjian M. Talpaz RE. Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia J Clin Oncol 11 1993 1055
27. J.M. Goldman J.F. Apperley L. Jones Bone marrow transplantation for patients with chronic myeloid leukemia N Engl J Med 314 1986 202
28. J.M. Goldman R.P. Gale M.M. Horowitz Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk of relapse associated with T-cell depletion Ann Intern Med 108 1988 806
29. J.M. Goldman R. Szydlo M.M. Horowitz Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase Blood 82 1993 2235
30. A. Gratwohl J. Hermans von Biezen A. No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: Results of a prospective randomized study Bone Marrow Transplant 10 1992 147
31. A. Gratwohl J. Hermans A.V. Biezen Splenic irradiation before bone marrow transplantation for chronic myeloid leukemia: Update of a prospective randomized study Leuk Lymphoma 11 suppl 1 1993 227
32. A. Gratwohl J. Hermans J. Apperley Acute graft-versus-host disease: Grade and outcome in patients with chronic myelogenous leukemia. Working Party on Chronic Leukemia of the European Group for Blood and Marrow Transplantation Blood 86 1995 813
33. G. Helenglass J. Treleaven P. Parikh Delayed engraftment associated with splenomegaly in patients undergoing bone marrow transplantation for chronic myeloid leukaemia Bone Marrow Transplant 5 1990 247
34. P.J. Henslee-Downey R.S. Parrish J.S. MacDonald Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant Transplantation 61 1996 738
35. M.M. Horowitz R.P. Gale P.M. Sondel Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1990 555
36. M.M. Horowitz S. Giralt R. Szydlo Effect of prior interferon therapy on outcome of HLA-identical sibling bone marrow transplants for chronic myelogenous leukemia (CML) in first chronic phase Blood 88 1996 682a
37. Italian Cooperative Study Group on Chronic Myeloid Leukaemia Evaluating survival after allogeneic bone marrow transplant for chronic myeloid leukemia in chronic phase: A comparison of transplant versus no-transplant in a cohort of 258 patients first seen in Italy between 1984 and 1986 Br J Haematol 85 1993 292
38. P. Kahls I. Schwarzinger G. Anderson A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic bone marrow transplantation for chronic myelogenous leukemia Blood 86 1995 2028
39. I. Khouri M.J. Keating D. Przepiorka Engraftment and induction of GVL with fludarabine-based non-ablative preparative regimen in patients with CLL and lymphoma Blood 88 suppl 1 1996 301a
40. H.J. Kolb J. Mittermueller C. Clemm Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 76 1990 2462
41. H.J. Kolb A. Schattenberg J.M. Goldman Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 86 1995 2041
42. M. Körbling D. Przepiorka Y.O. Huh Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts Blood 85 1995 1659
43. H. Link L. Arseniev O. Bähre Transplantation of allogeneic CD34+ blood cells Blood 87 1996 4903
44. D.I. Marks J.M. Goldman HLA-identical sibling bone marrow transplantation for chronic myeloid leukemia Atkinson K. Clinical Bone Marrow Transplantation: A Reference Textbook 1994 Cambridge University Press Cambridge 197
45. A.M. Marmont M.M. Horowitz R.P. Gale T-cell depletion of HLA-identical transplants in leukemia Blood 78 1991 2120
46. P.B. McGlave W.J. Miller D.D. Hurd Cytogenetic conversion following allogeneic bone marrow transplantation for advanced chronic myelogenous leukemia Blood 58 1981 1050
47. P.B. McGlave D.C. Arthur T.H. Kim Successful allogeneic bone marrow transplantation for patients in the accelerated phase of chronic granulocytic leukemia Lancet 2 1982 625
48. H. Ottinger D. Beelen H. Sayer Bone marrow transplantation from partially HLA-matched related donors in adults with leukaemia: The experience at the University Hospital of Essen, Germany Br J Haematol 92 1996 913
49. D.L. Porter M.S. Roth C. McGarigle Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia N Engl J Med 33 1994 100
50. O. Ringdén M.M. Horowitz P. Sondel Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 81 1993 109
51. P.A. Rowlings Current use and outcome of blood and marrow transplantation ABMTR Newsletter 3 1996 6
52. G.W. Santos Busulfan and cyclophosphamide versus cyclophosphamide and total body irradiation for marrow transplantation in chronic myelogenous leukemia—a review Leuk Lymphoma 11 suppl 1 1993 201
53. N. Schmitz P. Dreger M. Suttorp Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood 85 1995 1666
54. G.B. Segel W. Simon M.A. Lichtman Variables influencing the timing of marrow transplantation in patients with chronic myelogenous leukemia Blood 68 1986 1055
55. G. Silberman M.G. Crosse E.A. Peterson Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries N Engl J Med 331 1994 1063
56. W. Simon G.B. Segel M.A. Lichtman Upper and lower time limits in the decision to recommend marrow transplantation for patients with chronic myelogenous leukaemia Br J Haematol 70 1988 31
57. S. Slavin R. Or A. Nagler Allogeneic cell therapy for prevention of relapse in high-risk acute leukemia following allogeneic bone marrow transplantation: Control of GVHD by graded increments of donor lymphocyte infusion Blood 88 suppl 1 1996 418a
58. G. Socié A. Devergie T. Girinsky Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Étude des Greffes de Moelle Osseuse (GEGMO) Int J Radiat Oncol Biol Phys 20 1991 397
59. J.E. Sokal Prognosis in chronic myeloid leukaemia: Biology of the disease versus treatment Baillieres Clinical Haematol 1 1987 907
60. J.E. Sokal M. Baccarani S. Tura Prognostic discrimination among younger patients with chronic granulocytic leukemia: Relevance to bone marrow transplantation Blood 66 1985 1352
61. B. Speck M.M. Bortin R. Champlin Allogeneic bone marrow transplantation for chronic myelogenous leukemia Lancet 1 1984 665
62. R. Storb H.J. Deeg V. Farewell Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease Blood 68 1986 119
63. R. Storb H.J. Deeg J. Whitehead Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia N Engl J Med 314 1986 729
64. R. Storb H.J. Deeg M. Pepe Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial Blood 73 1989 1729
65. K.M. Sullivan P.L. Weiden R. Storb Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia Blood 73 1989 1720
66. R. Szydlo J.M. Goldman J.P. Klein Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings J Clin Oncol 15 1997 1767
67. E.D. Thomas R.A. Clift Indications for marrow transplantation in chronic myelogenous leukemia Blood 73 1989 861
68. E.D. Thomas C.D. Buckner M. Banaji One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation Blood 49 1977 511
69. E.D. Thomas C.D. Buckner R.A. Clift Marrow transplantation for acute nonlymphoblastic leukemia in first remission N Engl J Med 301 1979 597
70. E.D. Thomas R.A. Clift A. Fefer Marrow transplantation for the treatment of chronic myelogenous leukemia Ann Intern Med 104 1986 155
71. P.L. Weiden K.M. Sullivan N. Fluornoy Anti-leukemia effect of chronic graft-versus-host disease N Engl J Med 304 1981 1529